Yüklüyor......
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
Evolving intensiveness of colorectal cancer (CRC) treatment, including chemotherapeutics and targeted agents associations, in adjuvant and metastatic CRC (MCRC) settings, increased overall survival (OS) with individual variability of toxicity. Pharmacogenomic guidelines recommended pre-treatment ide...
Kaydedildi:
| Yayımlandı: | Pharmgenomics Pers Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678498/ https://ncbi.nlm.nih.gov/pubmed/33235483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S253586 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|